Albert David Limited (ALBERTDAVD.NS)
INR 1355.05
(-0.19%)
INR 1355.05
(-0.19%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.02 Billion INR | -44.85% |
| 2022 | 1.82 Billion INR | 12.24% |
| 2021 | 1.62 Billion INR | 10.55% |
| 2020 | 1.47 Billion INR | -19.98% |
| 2019 | 1.83 Billion INR | 2.45% |
| 2018 | 1.79 Billion INR | 0.76% |
| 2017 | 1.78 Billion INR | -7.66% |
| 2016 | 1.93 Billion INR | 1.29% |
| 2015 | 1.9 Billion INR | 2.42% |
| 2014 | 1.86 Billion INR | 17.39% |
| 2013 | 1.58 Billion INR | 6.46% |
| 2012 | 1.48 Billion INR | 7.04% |
| 2011 | 1.39 Billion INR | 9.09% |
| 2010 | 1.27 Billion INR | 12.19% |
| 2009 | 1.13 Billion INR | 10.77% |
| 2008 | 1.02 Billion INR | 15.66% |
| 2007 | 886.82 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 298.12 Million INR | 4.6% |
| 2023 Q3 | 488.09 Million INR | 3.8% |
| 2023 Q4 | 271.19 Million INR | -44.44% |
| 2023 Q1 | 491.24 Million INR | 12.41% |
| 2023 Q2 | 470.22 Million INR | -4.28% |
| 2023 FY | 1 Billion INR | -44.85% |
| 2022 Q1 | 488.87 Million INR | 36.46% |
| 2022 FY | 1.82 Billion INR | 12.24% |
| 2022 Q2 | 460.97 Million INR | -5.71% |
| 2022 Q4 | 437.01 Million INR | -0.67% |
| 2022 Q3 | 439.94 Million INR | -4.56% |
| 2021 Q2 | 424.17 Million INR | -2.84% |
| 2021 Q4 | 358.24 Million INR | -12.32% |
| 2021 FY | 1.62 Billion INR | 10.55% |
| 2021 Q1 | 436.57 Million INR | 40.66% |
| 2021 Q3 | 408.56 Million INR | -3.68% |
| 2020 Q3 | 387.92 Million INR | 7.56% |
| 2020 Q2 | 360.66 Million INR | -12.73% |
| 2020 Q1 | 413.27 Million INR | 21.48% |
| 2020 FY | 1.47 Billion INR | -19.98% |
| 2020 Q4 | 310.38 Million INR | -19.99% |
| 2019 Q4 | 340.2 Million INR | -28.53% |
| 2019 FY | 1.83 Billion INR | 2.45% |
| 2019 Q1 | 520.19 Million INR | 82.39% |
| 2019 Q2 | 503.05 Million INR | -3.29% |
| 2019 Q3 | 476.02 Million INR | -5.37% |
| 2018 Q2 | 522.1 Million INR | -0.7% |
| 2018 Q4 | 285.21 Million INR | -38.79% |
| 2018 FY | 1.79 Billion INR | 0.76% |
| 2018 Q1 | 525.78 Million INR | 43.31% |
| 2018 Q3 | 465.92 Million INR | -10.76% |
| 2017 Q2 | 487.48 Million INR | -0.26% |
| 2017 FY | 1.78 Billion INR | -7.66% |
| 2017 Q4 | 366.88 Million INR | -18.01% |
| 2017 Q3 | 447.46 Million INR | -8.21% |
| 2017 Q1 | 488.73 Million INR | 7.31% |
| 2016 Q3 | 465.38 Million INR | -2.19% |
| 2016 FY | 1.93 Billion INR | 1.29% |
| 2016 Q1 | 476.18 Million INR | 3.14% |
| 2016 Q2 | 475.81 Million INR | -0.08% |
| 2016 Q4 | 455.43 Million INR | -2.14% |
| 2015 Q3 | 468.02 Million INR | -11.61% |
| 2015 FY | 1.9 Billion INR | 2.42% |
| 2015 Q1 | 503.56 Million INR | 29.86% |
| 2015 Q2 | 529.48 Million INR | 5.15% |
| 2015 Q4 | 461.71 Million INR | -1.35% |
| 2014 Q3 | 473.43 Million INR | -9.13% |
| 2014 Q4 | 387.78 Million INR | -18.09% |
| 2014 Q2 | 521.01 Million INR | 9.0% |
| 2014 Q1 | 477.99 Million INR | 34.37% |
| 2014 FY | 1.86 Billion INR | 17.39% |
| 2013 Q3 | 401.36 Million INR | -5.18% |
| 2013 Q4 | 355.74 Million INR | -11.37% |
| 2013 Q1 | 404.2 Million INR | 37.15% |
| 2013 FY | 1.58 Billion INR | 6.46% |
| 2013 Q2 | 423.28 Million INR | 4.72% |
| 2012 Q1 | 385.85 Million INR | 7.26% |
| 2012 FY | 1.48 Billion INR | 7.04% |
| 2012 Q4 | 294.71 Million INR | -23.35% |
| 2012 Q3 | 384.47 Million INR | -9.08% |
| 2012 Q2 | 422.86 Million INR | 9.59% |
| 2011 Q4 | 359.74 Million INR | 10.91% |
| 2011 FY | 1.39 Billion INR | 9.09% |
| 2011 Q2 | 363.72 Million INR | 0.0% |
| 2011 Q3 | 324.35 Million INR | -10.82% |
| 2010 FY | 1.27 Billion INR | 12.19% |
| 2009 FY | 1.13 Billion INR | 10.77% |
| 2008 FY | 1.02 Billion INR | 15.66% |
| 2007 FY | 886.82 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sigachi Industries Limited | 579.88 Million INR | -76.956% |
| Ind-Swift Limited | 946.56 Million INR | -8.407% |
| Bajaj HealthCare Limited | 985.34 Million INR | -4.141% |
| Sakar Healthcare Limited | 204.07 Million INR | -402.819% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 98.156% |
| Innova Captab Limited | 931.03 Million INR | -10.216% |
| Divi's Laboratories Limited | 14.17 Billion INR | 92.758% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | 58.514% |
| Morepen Laboratories Limited | 1.98 Billion INR | 48.369% |
| Mankind Pharma Limited | 29.27 Billion INR | 96.495% |
| Sequent Scientific Limited | 2.9 Billion INR | 64.638% |
| Wanbury Limited | 978.96 Million INR | -4.819% |
| Laurus Labs Limited | 11.9 Billion INR | 91.384% |
| Nectar Lifesciences Limited | 932.7 Million INR | -10.019% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 91.185% |
| Alembic Limited | 872.45 Million INR | -17.616% |
| Hikal Limited | 4.46 Billion INR | 77.012% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 93.534% |
| Neuland Laboratories Limited | 2.92 Billion INR | 64.975% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 93.063% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 97.815% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 53.378% |
| Themis Medicare Limited | 1.12 Billion INR | 8.852% |
| RPG Life Sciences Limited | 1.63 Billion INR | 37.258% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 99.18% |
| Lupin Limited | 125.09 Billion INR | 99.18% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | 50.997% |
| Wockhardt Limited | 8.48 Billion INR | 87.899% |
| Vaishali Pharma Limited | 84.02 Million INR | -1121.182% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | 66.623% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -133.986% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 92.901% |
| FDC Limited | 3.49 Billion INR | 70.679% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.93% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -148.807% |
| Eris Lifesciences Limited | 4.94 Billion INR | 79.24% |
| Venus Remedies Limited | 1.91 Billion INR | 46.451% |
| ZIM Laboratories Limited | 1.01 Billion INR | -1.292% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | 27.697% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -1660.477% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | 52.81% |
| Shilpa Medicare Limited | 3.33 Billion INR | 69.223% |
| Ajanta Pharma Limited | 30.46 Billion INR | 96.631% |
| Hester Biosciences Limited | 908.84 Million INR | -12.907% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | 26.85% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | 59.824% |
| Gufic Biosciences Limited | 1.18 Billion INR | 13.521% |
| Windlas Biotech Limited | 1 Billion INR | -1.951% |
| Procter & Gamble Health Limited | 2.99 Billion INR | 65.743% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -7119.778% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -532.534% |
| Granules India Limited | 10.31 Billion INR | 90.05% |
| Aarti Drugs Limited | 1.16 Billion INR | 12.106% |
| Bal Pharma Limited | 555.62 Million INR | -84.683% |
| Alkem Laboratories Limited | 32.83 Billion INR | 96.875% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.334% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 4.472% |
| Medicamen Biotech Limited | 335.16 Million INR | -206.16% |
| Unichem Laboratories Limited | 6.72 Billion INR | 84.743% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -125.237% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -14946.144% |
| Valiant Laboratories Limited | 138.02 Million INR | -643.429% |
| Orchid Pharma Limited | 800.77 Million INR | -28.145% |
| Medico Remedies Limited | 59.67 Million INR | -1619.559% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | 51.692% |
| Ipca Laboratories Limited | 18.98 Billion INR | 94.596% |
| Brooks Laboratories Limited | 51.18 Million INR | -1904.977% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -196.889% |
| Piramal Enterprises Limited | 63.65 Billion INR | 98.388% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 95.21% |
| NATCO Pharma Limited | 10.05 Billion INR | 89.798% |
| Suven Life Sciences Limited | 109.75 Million INR | -834.986% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -2123.215% |
| Strides Pharma Science Limited | 9.16 Billion INR | 88.8% |
| Indoco Remedies Limited | 12.06 Billion INR | 91.492% |
| Alpa Laboratories Limited | 127.38 Million INR | -705.579% |
| Lasa Supergenerics Limited | 291.17 Million INR | -252.417% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 66.649% |